← Leaderboards
Luana Fioriti
Nanonewron Llc
$1,908,961
Attributed
$3,817,921
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2023–25$2M$1.5M$1M$500K$0
'23
'24
'25
Funding mix
By agency
NIH$3,817,921 · 3
By mechanism
RF1$1,941,311 · 1
R01$1,376,782 · 1
R41$499,828 · 1
Top collaborators
- Catarina M. Quinzii3 shared
- Luciano D'Adamio1 shared
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposPreventImpairmentSynaptic TransmissionImpaired CognitionS DiseaseMediatingIn VivoProductionSynaptic PlasticityTherapeutic TargetToxic EffectDementiaFunctional DisorderTau ProteinsBrainAnimal ModelCellsMemoryBehavioral ImpairmentHippocampusBehavioralEnzymesExperimental Study
Grant awards (4)
Role of SUMOylation in Mitochondrial/Synaptic Axis Dysfunction Induced by Abnormal Tau in FTD$1,941,311
RF1 · FY2025 · NS
Role of SUMOylation in Mitochondrial/Synaptic Axis Dysfunction Induced by Abnormal Tau in FTD$666,920
R01 · FY2024 · NS
Role of SUMOylation in Mitochondrial/Synaptic Axis Dysfunction Induced by Abnormal Tau in FTD$709,862
R01 · FY2023 · NS
Discovery of therapeutic nanobodies targeting brain TNF-α for the treatment of Alzheimer Disease$499,828
R41 · FY2023 · AG · contact PI